57 results
PRE 14A
SAGE
Sage Therapeutics Inc
8 Dec 23
Preliminary proxy
8:30am
or investment power with respect to securities. Except as noted by footnote, and subject to community property laws where applicable, we believe, based
8-K
EX-99.1
akw0 5juy6udoo7r2d
3 May 22
Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
6:45am